Elevance Health Future Growth
Future criteria checks 2/6
Elevance Health is forecast to grow earnings and revenue by 12.7% and 6.7% per annum respectively. EPS is expected to grow by 15.8% per annum. Return on equity is forecast to be 17.6% in 3 years.
Key information
12.7%
Earnings growth rate
15.8%
EPS growth rate
Healthcare earnings growth | 27.0% |
Revenue growth rate | 6.7% |
Future return on equity | 17.6% |
Analyst coverage | Good |
Last updated | 18 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 200,355 | 8,785 | 8,792 | 9,164 | 12 |
12/31/2025 | 187,289 | 7,530 | 7,579 | 8,049 | 15 |
12/31/2024 | 175,111 | 6,343 | 5,032 | 5,443 | 12 |
9/30/2024 | 174,015 | 6,418 | 871 | 2,131 | N/A |
6/30/2024 | 171,719 | 6,691 | 820 | 2,067 | N/A |
3/31/2024 | 171,745 | 6,244 | 2,296 | 3,570 | N/A |
12/31/2023 | 171,340 | 5,987 | 6,765 | 8,061 | N/A |
9/30/2023 | 168,626 | 5,996 | 8,246 | 9,514 | N/A |
6/30/2023 | 165,716 | 6,310 | 10,571 | 11,825 | N/A |
3/31/2023 | 160,676 | 6,094 | 11,128 | 12,327 | N/A |
12/31/2022 | 156,599 | 5,894 | 7,247 | 8,399 | N/A |
9/30/2022 | 153,251 | 6,166 | 10,395 | 11,589 | N/A |
6/30/2022 | 149,134 | 6,072 | 8,022 | 9,169 | N/A |
3/31/2022 | 144,353 | 6,228 | 7,263 | 8,400 | N/A |
12/31/2021 | 138,643 | 6,158 | 7,277 | 8,364 | N/A |
9/30/2021 | 133,883 | 5,518 | 9,480 | 10,505 | N/A |
6/30/2021 | 129,219 | 4,231 | 5,778 | 6,851 | N/A |
3/31/2021 | 124,632 | 4,714 | 9,657 | 10,678 | N/A |
12/31/2020 | 121,868 | 4,572 | 9,667 | 10,688 | N/A |
9/30/2020 | 117,449 | 4,955 | 7,108 | 8,202 | N/A |
6/30/2020 | 112,965 | 5,916 | 9,960 | 11,019 | N/A |
3/31/2020 | 109,167 | 4,779 | 5,899 | 6,946 | N/A |
12/31/2019 | 104,212 | 4,807 | 4,984 | 6,061 | N/A |
9/30/2019 | 100,165 | 4,298 | 4,151 | 5,197 | N/A |
6/30/2019 | 96,742 | 4,074 | 3,007 | 4,137 | N/A |
3/31/2019 | 94,220 | 3,989 | 2,018 | 3,242 | N/A |
12/31/2018 | 92,091 | 3,750 | 2,619 | 3,827 | N/A |
9/30/2018 | 91,409 | 4,556 | 891 | 2,063 | N/A |
6/30/2018 | 90,584 | 4,344 | N/A | 3,861 | N/A |
3/31/2018 | 90,061 | 4,145 | N/A | 3,712 | N/A |
12/31/2017 | 90,049 | 3,843 | N/A | 4,185 | N/A |
9/30/2017 | 89,055 | 2,980 | N/A | 5,763 | N/A |
6/30/2017 | 88,038 | 2,851 | N/A | 4,322 | N/A |
3/31/2017 | 87,083 | 2,777 | N/A | 4,599 | N/A |
12/31/2016 | 84,862 | 2,470 | N/A | 3,270 | N/A |
9/30/2016 | 83,364 | 2,282 | N/A | 3,943 | N/A |
6/30/2016 | 81,866 | 2,319 | N/A | 3,322 | N/A |
3/31/2016 | 80,412 | 2,398 | N/A | 3,825 | N/A |
12/31/2015 | 79,158 | 2,560 | N/A | 4,212 | N/A |
9/30/2015 | 77,959 | 2,886 | N/A | 3,472 | N/A |
6/30/2015 | 76,605 | 2,862 | N/A | 3,734 | N/A |
3/31/2015 | 75,066 | 2,734 | N/A | 3,632 | N/A |
12/31/2014 | 73,886 | 2,560 | N/A | 3,369 | N/A |
9/30/2014 | 72,792 | 2,362 | N/A | 3,337 | N/A |
6/30/2014 | 72,090 | 2,385 | N/A | 4,129 | N/A |
3/31/2014 | 71,307 | 2,453 | N/A | 3,483 | N/A |
12/31/2013 | 71,024 | 2,634 | N/A | 3,052 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: E1LV34's forecast earnings growth (12.7% per year) is above the savings rate (10.4%).
Earnings vs Market: E1LV34's earnings (12.7% per year) are forecast to grow faster than the BR market (12.6% per year).
High Growth Earnings: E1LV34's earnings are forecast to grow, but not significantly.
Revenue vs Market: E1LV34's revenue (6.7% per year) is forecast to grow slower than the BR market (7.4% per year).
High Growth Revenue: E1LV34's revenue (6.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: E1LV34's Return on Equity is forecast to be low in 3 years time (17.6%).